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SUMMARY
Five human interferon-a (leukocyte) subtypes derived from genes cloned in Escherichia coil have been compared for their ability to induce antiviral activity against vesicular stomatitis virus infection of various mammalian cell cultures. These interferons, designated LeIF-A (IFN-ct2) , -B, -C, -D (IFN-a~) and LeIF-F, show different relative activities when assayed on human; bovine, hamster, mouse, rabbit and monkey cell lines. As with a natural human buffy-coat interferon-a preparation, three subtypes (LeIF-B, -C and -D) showed considerable activity on RK-13 rabbit cells, but two (LeIF-D and -F) also showed some activity on mouse L-929 cells. Of the five interferon subtypes examined, LeIF-F demonstrated the highest degree of species specificity.
Preparations of human interferon-a (leukocyte) have shown antiviral activity in various mammalian cell lines and this has been postulated to arise from the presence of distinct molecular subtypes of interferon (Gresser et al., 1974; Stewart & Desmyter, 1975; Desmyter & Stewart, 1976; Rubinstein et al., 1981) Human interferon-a preparations generally show some molecular heterogeneity with most activity at a mol. wt. of about 18 000 and some at a mol. wt. of 22 000, while all activity was found to have a mol. wt. of 18 000 after treatment with glycosidases (Bridgen et al., 1977; Otto et al., 1980) . Thus, glycosylation, although possible for a fraction of the natural materials, would not seem to be essential for antiviral activity of human interferon-a and the protein moiety would seem to be essentially homogeneous with regard to mol. wt.
Cloning of interferons in bacteria by recombinant DNA techniques has revealed that the human interferons-a are a family of related proteins of 165 or 166 amino acid residues (Goeddel et al., 1980 Nagata et al., 1980a, b; Yelverton et al., 1981) . In the present study we have compared the induction of antiviral activity in various mammalian cell cultures by five different human interferon-a subtypes obtained by cloning plasmids containing human interferon-a genes in Escherichia coli. The amino acid sequences of the five interferons, all derived by cloning from mRNA, differ in 18 to 32 positions and are termed LelF-A, -B, -C, -D, -F. LelF-E is a similar interferon gene, although it cannot be expressed because it contains several stop codons . The LelF-A and -D of Goeddel et al. (1981) correspond to IFN-a 2 and IFN-a~ respectively, of Nagata et al. (1980b Grand Island, New York, U.S.A. Vesicular stomatitis virus (VSV) Indiana strain, was purchased from the American Type Culture Collection and passaged in BHK-21 cells. The construction of bacterial plasmids containing the various human leukocyte interferon genes and preparation of interferon extracts from bacterial cells have been described previously (Goeddel et al., 1980 . The supernatants generated by this extraction procedure were collected and used in plaque reduction assays (Yelverton et al., 1981) or cytopathic effect inhibition assays (Campbell et al., 1975) using the National Institutes of Health leukocyte interferon standard G-023-901-527. These preparations of interferons derived from bacteria had specific activities in a range from 3.2 x 104 to 1.6 x 105 U/mg protein and extracts of bacterial cells containing plasmids lacking interferon gene sequences had no antiviral activity. All samples from pH 2 treatments, 56 °C treatments and antibody neutralization experiments were measured for residual interferon activity by cytopathic effect inhibition using WISH cells and VSV. Antibody neutralization of the interferon preparations was determined with polyvalent rabbit anti-LelF and anti-FIF antibodies kindly supplied by the Antiviral Substances Programme of the National Institutes of Allergy and Infectious Diseases (NIAID). These anti-FIF and anti-LeIF antibody preparations had titres of 1024 and 10000/ml after incubation with 20 units of their respective interferon standards. A natural human buffy-coat interferon preparation was obtained from Dr Norwood Hill, Wadley Institute for Molecular Medicine, Dallas, Texas, U.S.A. This natural material had a specific activity of 1 x 106 U/mg protein.
Different cells lines have shown wide variations in response to the antiviral effects of natural interferons when tested either by plaque reduction or inhibition of cytopathic effects (Stewart, 1979; Lazar et al., 1980; Stewart & Havell, 1980) . We examined the in vitro activity of various cloned interferon-a subtypes in eight different mammalian cell cultures. The results presented in Table 1 showed that all the cloned interferon subtypes had higher activity on bovine MDBK cells than on human cells and that two (LeIF-D and -F) showed some activity on mouse L-929 cells. As has been reported for natural human-fl (fibroblast) and -a (leukocyte) interferon preparations (Desmyter et al., 1970; McGill et al2, 1976) , four of the cloned interferons demonstrated relatively high antiviral activity on a continuous rabbit cell line RK-13. In contrast, only LeIF-D and the natural leukocyte interferon preparation caused pronounced protection of primary rabbit kidney cells against VSV infection. The cloned leukocyte interferon subtype LeIF-F demonstrated the highest degree of species specificity of all the interferons tested. Thus, it appears that the cloned human interferon subtypes differ * Vero cell monolayers were treated for 18 to 20 h with half-step log~0 dilutions of interferon prior to inoculation with 40 to 50 p.f.u, of the indicated virus. The data are presented as the reciprocal of the dilution of the interferon preparation causing 50 % reduction of virus plaque formation.
significantly from one to another in their ability to confer protection against VSV infection of different cell lines.
These results raised the possibility that variation in the antiviral activity of natural human leukocyte interferon preparations against different viruses may be due to differences in the properties of the constituent subtypes. We, therefore, compared the antiviral activity of the cloned interferon subtypes against VSV or EMC virus infection of Vero cells. The results demonstrated that the various cloned interferon subtypes have different relative activities against VSV and EMC virus in a monkey cell line ( Table 2 ). The differences in antiviral activity against EMC virus of the various cloned interferons in these experiments did not vary greatly except for LeIF-F, for which higher activity was observed. The variations in the relative activity in different cells indicate that the interferon subtypes may differentially affect biochemical pathways induced by interferon, such as phosphorylation of eIF-2 or activation of RNase F (Baglioni, 1979; D. A. Epstein, C. W. Czarniecki, H. Jacobsen & R. M. Friedman, unpublished results). That different viruses respond to one or other of the interferon-induced biochemical pathways is indicated by studies with natural, unfractionated mouse interferon preparations (Czarniecki et al., 1981; D. A. Epstein et al., unpublished results) .
Since the various cloned genes for the interferon subtypes were produced in E. eoli from essentially the same series of genetic manipulations and since the interferons were extracted in the same way from similarly grown cultures, one might expect their yield in terms of amounts of protein to be essentially identical. The use of a cell-flee system and bacterial minicells has demonstrated that similar amounts of interferon subtypes are made from the recombinant plasmid DNAs, the greatest difference in yield being no more than fivefold in minicells (Streuli et al., 1981) and twofold in the cell-flee system (P. K. Week, S. Apperson, N. Stebbing, Goeddel, unpublished results) . Thus the differences in activity of the various interferon subtypes are primarily due to inherent differences in specific activity. The antigenic specificities of the cloned interferons-ct was determined by antibody neutralization tests. The NIAID anti-LelF antibody preparation neutralized 20 units of the cloned interferon subtypes at dilutions of 1 : 640 for LeIF-A and:B, 1 : 240 for LeIF-C and -F, and 1 : 60 for LeIF-D. The anti-FIF antibody had no effect on antiviral activity of any of the interferon-ct subtypes. All the interferon subtypes showed similar stability to prolonged incubation at pH 2. Only one of the cloned interferons (LeIF-D) lost a portion of its antiviral activity and the loss was only 25 % after 24 h, the same as that observed for the natural leukocyte preparation. Heat treatment of the various interferon subtypes indicated that LeIF-D was the most stable of the cloned interferons, and that LeIF-A, -B, -C and -F lost at least 90% of their antiviral activity following 3 h incubation at 56 °C. LeIF-D lost 75% activity after 3 h heating and 90% after 6 h. Nevertheless, the properties of the cloned leukocyte interferons did not differ greatly from the known characteristics of the natural material in terms of heat or acid lability (Stewart, 1979) .
The various interferon-a subtypes investigated in the present study appear to have distinct properties in terms of their ability to induce antiviral activity in various mammalian cell cultures. This conclusion is supported by earlier observations showing that antiviral activity of natural interferon-a preparations on rabbit cells is associated with a particular electrophoretic fraction (Stewart & Desmyter, 1975) , and that antiviral activity on cat cells is not affected by SDS treatments under reducing conditions, but activity on human cells is destroyed by such treatment (Desmyter & Stewart, 1976) . However, the relationship between the cloned subtypes and the molecular heterogeneity of natural leukocyte interferon preparations and their antiviral properties is not clear. To date, antiviral activity of natural leukocyte interferons has been compared in various cell lines using only impure preparations that are presumably mixtures of the various leukocyte interferons. Antiviral activity of natural human interferon-a preparations on mouse cells is only a fraction of a percent of that on WISH cells, but two of the cloned subtypes (LeIF-D and -F) show about 5 % cross-species activity on L-929 cells. The lack of activity in mouse cells of the natural leukocyte preparation could be due to antagonistic interactions between the interferon subtypes and studies with two of the cloned interferon subtypes (LeIF-A and -D) have already demonstrated that there are interactive effects .
The frequency of the various cloned interferon subtypes in natural leukocyte interferon preparations is uncertain. However, assuming that mRNA frequency in induced cells is proportional to the amount of the translation products, LeIF-A and LeIF-D would appear to be the most frequent subtypes, corresponding to about 70 % of the total int~rferons present in buffy-coat or KG-1 cell line preparations (Nagata et at., 1980 b; Goeddel et al., 1981) . On the basis of mRNA frequency, LeIF-D should be the predominant interferon subtype in natural leukocyte interferon preparations and this is supported by the observation that the spectrum of activity of LeIF-D on a range of mammalian cells corresponds most closely to that of a buffy-coat interferon preparation (Table 1) .
The antiviral activity of the different cloned interferon subtypes in cell cultures may be modified in vivo where cell-mediated effects may be of paramount importance (Gidlund et al., 1978; Herberman et al., 1978; Stebbing et al., 1978) . That interferon preparations inactive in cell cultures can be active in vivo has been already demonstrated (Schellekens et al., 1979) . Moreover, LeIF-A, which has relatively low activity in rabbit cells (Table 1 ) has proved to be as effective as a human buffy-coat interferon preparation against HSV-1 infection of the rabbit eye (Smolin et al., 1981) . However, the present results indicate that the various leukocyte interferon subtypes have distinct biological properties and may prove optimally useful against different virus infections. Such possibilities are under investigation using the interferons discussed here, as well as an examination of induction of various biochemical pathways following treatment with the various cloned interferon subtypes. 
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